ResearcherYonsei UniversityNo recent work listed

Ikhyun Jun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2160-1679; OpenAlex author ID A5042881976. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. Co-author DOI 10.1038/bjc.2017.355 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Min Goo Lee · 1 shared paper, 2017 · strength 0.06
- Paper ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. DOI 10.1038/bjc.2017.355 ↗
Joon Seong Park · 1 shared paper, 2017 · strength 0.06
- Paper ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. DOI 10.1038/bjc.2017.355 ↗
Hei‐Cheul Jeung · 1 shared paper, 2017 · strength 0.06
- Paper ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. DOI 10.1038/bjc.2017.355 ↗
Hyung Soon Park · 1 shared paper, 2017 · strength 0.06
- Paper ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. DOI 10.1038/bjc.2017.355 ↗
Dong Sup Yoon · 1 shared paper, 2017 · strength 0.06
- Paper ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. DOI 10.1038/bjc.2017.355 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.